In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V1 and V2

Khurram Jamil,1 Stephen Chris Pappas,2 Krishna R Devarakonda1 1Clinical Development, Mallinckrodt Pharmaceuticals, Bedminster, 2Orphan Therapeutics, LLC, Lebanon, NJ, USA Abstract: Terlipressin, a synthetic, systemic vasoconstrictor with selective activity at ­vasopressin-1 (V1) receptors, i...

Full description

Bibliographic Details
Main Authors: Jamil K, Pappas SC, Devarakonda KR
Format: Article
Language:English
Published: Dove Medical Press 2017-12-01
Series:Journal of Experimental Pharmacology
Subjects:
Online Access:https://www.dovepress.com/in-vitro-binding-and-receptor-mediated-activity-of-terlipressin-at-vas-peer-reviewed-fulltext-article-JEP